PharMetrics, Inc. provides patient-level intelligence solutions to support pricing and market access as it relates to identifying at-risk, treatment indicated populations, defining value-based messaging for managed markets, and demonstrating the clinical, economic, and patient benefits associated with a particular therapy. The company was founded in 1998 and is headquartered in Watertown, Massachusetts.
The PharMetrics® Integrated Database is the largest non-Payer owned integrated claims database of commercial insurers in the U.S. This de-identified, Integrated Database includes medical and pharmacy claims for more than 70 million members from more than 100 health plans across the U.S. The Integrated Database includes inpatient and outpatient claims, diagnoses and procedures based on ICD-9 and CPT-4 codes, as well as retail and mail order pharmacy claims.
The records in the PharMetrics® Integrated Database are representative of the national commercially insured population, and include a variety of demographic measures such as age, gender and plan type. This longitudinal data has an average member enrollment period of two years.
As of July 01, 2005, PharMetrics, Inc. is a subsidiary of IMS Health, Inc.
IMS Health, Inc.
The demand for reliable market intelligence and accountability in global healthcare has never been greater. From researchers and payers to government agencies and pharmaceutical manufacturers, healthcare stakeholders need to better understand the role prescription drugs play in delivering high-quality, cost-effective care. At the same time, pharmaceutical companies face unprecedented competition for market share and pressures to maximize brand lifecycles, all while proving the value of their medicines.
In today’s complex healthcare marketplace, a growing set of audiences depend on IMS to yield the most accurate perspective of global market dynamics.
Organizing a vast array of healthcare data and facts into solid, relevant metrics to help answer key questions is an enormous undertaking. IMS can apply insight and capabilities to a tremendously rich set of data assets and analytics. We are the gold standard in pharmaceutical and healthcare market intelligence, relied on by virtually all of the world’s largest pharmaceutical and biotech companies — along with government agencies, policymakers, researchers and financial analysts around the globe.
Our end-to-end solutions — integrating unparalleled information, analytics, consulting and services — play a central role in supporting high-quality, cost-effective healthcare. Our people bring the facts and figures to life, leveraging our extensive global network and expertise.